Autori: (broj koautora 617)
| Naslov | Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world (Article) |
| Autori | Kapelios Chris J ... Seferovic Petar M  ... Seferovic Petar M ... (broj koautora 617)
|
| Info | EUROPEAN JOURNAL OF HEART FAILURE, (2019), vol. 21 br. 11, str. 1383-1397 |
| Projekat | Abbott Laboratories; Amgen Cardiovascular; AstraZeneca; Bayer AG; Boehringer Ingelheim; Boston Scientific; Bristol Myers Squibb and Pfizer Alliance; Daiichi Sankyo Europe GmbHDaiic |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
     |
